If you liked this article you might like

Biotech Premarket Movers: Ardelyx, Acorda Therapeutics, Medicines Co.
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Investors Scour Big Pharma M&A Scene for Next Big Takeover